Review
doi: 10.1038/nrc1691.
The concept of synthetic lethality in the context of anticancer therapy
Affiliations
- PMID: 16110319
- DOI: 10.1038/nrc1691
Item in Clipboard
Review
The concept of synthetic lethality in the context of anticancer therapy
Nat Rev Cancer.
2005 Sep.
Abstract
Two genes are synthetic lethal if mutation of either alone is compatible with viability but mutation of both leads to death. So, targeting a gene that is synthetic lethal to a cancer-relevant mutation should kill only cancer cells and spare normal cells. Synthetic lethality therefore provides a conceptual framework for the development of cancer-specific cytotoxic agents. This paradigm has not been exploited in the past because there were no robust methods for systematically identifying synthetic lethal genes. This is changing as a result of the increased availability of chemical and genetic tools for perturbing gene function in somatic cells.
Similar articles
-
Chromosome instability and tumor lethality suppression in carcinogenesis.J Cell Biochem. 2008 Dec 15;105(6):1327-41. doi: 10.1002/jcb.21937. J Cell Biochem. 2008. PMID: 18821574
-
Application of the concept synthetic lethality toward anticancer therapy: a promise fulfilled?Cancer Lett. 2014 Sep 28;352(1):59-65. doi: 10.1016/j.canlet.2013.08.019. Epub 2013 Aug 17. Cancer Lett. 2014. PMID: 23962561 Review.
-
Harnessing synthetic lethal interactions in anticancer drug discovery.Nat Rev Drug Discov. 2011 May;10(5):351-64. doi: 10.1038/nrd3374. Nat Rev Drug Discov. 2011. PMID: 21532565 Free PMC article. Review.
-
Comprehensive analysis and prediction of synthetic lethality using subcellular locations.Genome Inform. 2005;16(1):150-8. Genome Inform. 2005. PMID: 16362917
-
Systematic analysis of cancer-specific synthetic lethal interactions provides insight into personalized anticancer therapy.FEBS J. 2023 Mar;290(6):1531-1548. doi: 10.1111/febs.16643. Epub 2022 Oct 17. FEBS J. 2023. PMID: 36181326
Cited by
-
Poly (ADP-ribose) polymerase inhibitors: on the horizon of tailored and personalized therapies for epithelial ovarian cancer.Curr Opin Oncol. 2012 Sep;24(5):564-71. doi: 10.1097/CCO.0b013e3283564230. Curr Opin Oncol. 2012. PMID: 22759740 Free PMC article. Review.
-
RAS Synthetic Lethal Screens Revisited: Still Seeking the Elusive Prize?Clin Cancer Res. 2015 Apr 15;21(8):1802-9. doi: 10.1158/1078-0432.CCR-14-2180. Clin Cancer Res. 2015. PMID: 25878361 Free PMC article. Review.
-
On biomarkers and pathways in rectal cancer: What's the target?World J Gastrointest Surg. 2012 Dec 27;4(12):275-7. doi: 10.4240/wjgs.v4.i12.275. World J Gastrointest Surg. 2012. PMID: 23493582 Free PMC article.
-
Saccharomyces cerevisiae genetics predicts candidate therapeutic genetic interactions at the mammalian replication fork.G3 (Bethesda). 2013 Feb;3(2):273-82. doi: 10.1534/g3.112.004754. Epub 2013 Feb 1. G3 (Bethesda). 2013. PMID: 23390603 Free PMC article.
-
Using functional genetics to understand breast cancer biology.Cold Spring Harb Perspect Biol. 2010 Jul;2(7):a003327. doi: 10.1101/cshperspect.a003327. Epub 2010 Jun 2. Cold Spring Harb Perspect Biol. 2010. PMID: 20519343 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
